Highlights: CfDNA offers a non-invasive way to detect and monitor diseases like cancer and genetic conditions
Vous n'êtes pas connecté
Southwest Research Institute (SwRI) in the USA, has developed a unique technology to screen new DNA-targeting therapeutics designed to treat cancer and other diseases. Combining SwRI’s 3D drug screening software tool and machine learning techniques, SwRI scientists successfully predicted the DNA binding affinity and cancer cell toxicity for a variety of relevant drug compounds under [...]
Highlights: CfDNA offers a non-invasive way to detect and monitor diseases like cancer and genetic conditions
Drug discovery is made efficient by speeding up from years to months by combining large-scale screening with advanced simulations.
Drug discovery is made efficient by speeding up from years to months by combining large-scale screening with advanced simulations.
TC BioPharm (Holdings) PLC (TC BioPharm), a clinical stage biotechnology company developing platform allogeneic gamma─delta T cell therapies for...
Dietary compounds may help inhibit cancer cell growth, highlighting the potential of nucleic acids in cancer prevention.
Relay Therapeutics, Inc., a clinical─stage precision medicine company transforming the drug discovery process by combining leading─edge...
Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as...
Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as...
What is circulating cell-free DNA, and how can it change healthcare? Discover how cfDNA offers non-invasive insights for cancer, prenatal care, and...
Researchers from Cincinnati Children's Hospital and the University of Cincinnati College of Medicine have developed a novel approach to increase...